Michael HallekExecutive Steering Committee Member

Professor Michael Hallek is the Director of Clinic I for Internal Medicine and Associated Principle Investigator at the University Hospital Cologne, Cologne, DE, and the Director of the Center of Integrated Oncology (CIO) in Aachen, Bonn, Cologne, and Düsseldorf, DE.

Prof. Hallek obtained his medical degree from the Ludwig-Maximilians-Universität München, DE, in 1985 and was a Research Associate at the Dana Farber Cancer Institute and Harvard Medical School, Boston, US, from 1990–1992. He became a senior consultant at the Ludwig-Maximilians-Universität München, DE, between 1995−2003. His main research focus is chronic lymphocytic leukemia.

Positions of responsibility/awards:

• Chairman of Scientific Committee, European School of Haematology since 2018
• Awarded the German Cancer Award and the Arthur Burkhardt Award in 2017
• Awarded the Walter-Siegenthaler Medal in 2016
• Executive Chairman of the German Society of Hematology and Medical Oncology (DGHO) since 2018
• Scientific Board Member of the Bundesärztekammer (German Chamber of Physicians)
• Editor-in-Chief of Journal of Oncology Research and Treatment
• Member of the German National Academy of Sciences (Leopoldina)
• Chairman of the Clinical Research Unit 286 “DNA damage response in CLL” (DFG)
• Awarded the Binet-Rai Medal of the International Workshop on CLL (iwCLL) in 2013
• Awarded the Paul Martini Prize in 2012
• Scientific Committee (Core Group) iwCLL since 2000
• Research Group Leader, Gene Center Munich between 1994−2005

Founder and Chairman of the German CLL Study Group since 1996